200
Participants
Start Date
June 1, 2019
Primary Completion Date
May 30, 2022
Study Completion Date
May 30, 2022
Budesonide 0.25 MG/ML Inhalant Solution
"Both medications used for the intervention groups are Glucocorticoids. The effect of glucocorticoids in AP can be attributed to their anti-inflammatory actions. They inhabit the formation of the pro-inflammatory mediators in the endothelial cells of the airways. This will decreases the inflammatory reaction at the pharynges which result in a reduction of throat pain.~Studies have shown that the use of a single dose of systemic glucocorticoids for acute pharyngitis did not result in significant adverse events and no serious adverse events were reported (7) (8)."
Dexamethasone
"Both medications used for the intervention groups are Glucocorticoids. The effect of glucocorticoids in AP can be attributed to their anti-inflammatory actions. They inhabit the formation of the pro-inflammatory mediators in the endothelial cells of the airways. This will decreases the inflammatory reaction at the pharynges which result in a reduction of throat pain.~Studies have shown that the use of a single dose of systemic glucocorticoids for acute pharyngitis did not result in significant adverse events and no serious adverse events were reported (7) (8)."
Normal saline
Placebo for the control group.
Armed Forces Hospital, Muscat
Mortaafah Armed Medical Hospital (MAM), Muscat
Royal Oman Police Hospital, Muscat
Oman Medical Speciality Board
OTHER_GOV